Crossmark

Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study

Crossref DOI link: https://doi.org/10.1016/j.aohep.2022.100769

Published Print: 2023-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Barcelos, Samantha Thifani Alrutz

Silva-Sperb, Amanda Souza

Moraes, Helena Abadie

Longo, Larisse

de Moura, Bruna Concheski

Michalczuk, Matheus Truccolo

Uribe-Cruz, Carolina

Cerski, Carlos Thadeu Schmidt

da Silveira, Themis Reverbel

Dall'Alba, Valesca http://orcid.org/0000-0002-8896-3199
Álvares-da-Silva, Mário Reis
Funding

Funding for this research was provided by:

Hospital de Clínicas de Porto Alegre
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2022-10-05
More Information

This article is maintained by: Elsevier

Article Title: Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2022.100769

Content Type: article

Copyright: © 2022 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below